Jump to content
Main menu
Main menu
move to sidebar
hide
Navigation
Main page
Recent changes
Random page
freem
Search
Search
Appearance
Create account
Log in
Personal tools
Create account
Log in
Pages for logged out editors
learn more
Contributions
Talk
Editing
Openai/69729ae6-bd00-8005-8892-1acd564602bd
(section)
Add languages
Page
Discussion
English
Read
Edit
Edit source
View history
Tools
Tools
move to sidebar
hide
Actions
Read
Edit
Edit source
View history
General
What links here
Related changes
Special pages
Page information
Appearance
move to sidebar
hide
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
===== 3. Culturelle Baby Calm + Colic Probiotic Drops (i-Health/Culturelle – Canada): B. longum KABP-042 + Pediococcus pentosaceus KABP-041 ===== Strains & Product: Contains a two-strain mix: Bifidobacterium longum subsp. longum KABP™-042 and Pediococcus pentosaceus KABP™-041. This specific combination (branded as AB-Kolicare® by AB-Biotics) was developed to target infant colic and is available in certain markets (e.g. sold as Culturelle “Calm + Colic” Drops in Canada)cdhf.ca<ref>{{cite web|title=cdhf.ca|url=https://cdhf.ca/en/baby-probiotics-a-complete-guide-to-treating-colic/#:~:text=Studies%20show%20that%20certain%20probiotics,as%20little%20as%20seven%20days|publisher=cdhf.ca|access-date=2026-01-23}}</ref>. Each 5 drops provides 1×10^9 CFU total (strains in equal amounts) in a sunflower oil suspensionlink.springer.com<ref>{{cite web|title=link.springer.com|url=https://link.springer.com/article/10.1007/s00431-024-05806-x#:~:text=Biogaia%C2%AE%20,Biotics%C2%AE%2C%20S.A.%20%28Spain%29%3B%20%E2%80%9CBL|publisher=link.springer.com|access-date=2026-01-23}}</ref>. These strains were originally isolated for their gut health benefits and resilience in infants. Clinical Evidence: This B. longum + Pediococcus combo has strong evidence from recent trials. Notably, a 2024 head-to-head RCT (112 colicky infants, 2–12 weeks old) compared AB-Kolicare drops against L. reuteri DSM 17938link.springer.com<ref>{{cite web|title=link.springer.com|url=https://link.springer.com/article/10.1007/s00431-024-05806-x#:~:text=We%20aimed%20to%20compare%20the,and%20daily|publisher=link.springer.com|access-date=2026-01-23}}</ref>link.springer.com<ref>{{cite web|title=link.springer.com|url=https://link.springer.com/article/10.1007/s00431-024-05806-x#:~:text=trial%20was%20conducted%20in%20112,IQR%5D%29%20became|publisher=link.springer.com|access-date=2026-01-23}}</ref>. After 3 weeks, the bi-strain group had superior outcomes: 84.6% were treatment responders (≥50% reduction in crying) by day 14, versus 59.3% in the L. reuteri group (p=0.004)link.springer.com<ref>{{cite web|title=link.springer.com|url=https://link.springer.com/article/10.1007/s00431-024-05806-x#:~:text=time%20from%20baseline%2C%20as%20reported,adverse%20events%20between%20the%20groups|publisher=link.springer.com|access-date=2026-01-23}}</ref>. Median daily crying/fussing time was also significantly lower with B. longum + P. pentosaceus at days 7, 14, and 21 (e.g. 29 minutes on day 21 vs 67 minutes with L. reuteri; p=0.011)link.springer.com<ref>{{cite web|title=link.springer.com|url=https://link.springer.com/article/10.1007/s00431-024-05806-x#:~:text=Study%20groups%20were%20comparable%20at,adverse%20events%20between%20the%20groups|publisher=link.springer.com|access-date=2026-01-23}}</ref>link.springer.com<ref>{{cite web|title=link.springer.com|url=https://link.springer.com/article/10.1007/s00431-024-05806-x#:~:text=14%20%2884.6,adverse%20events%20between%20the%20groups|publisher=link.springer.com|access-date=2026-01-23}}</ref>. Both treatments were safe and well-tolerated, but the two-strain combo achieved a higher response rate and greater reduction in symptomslink.springer.com<ref>{{cite web|title=link.springer.com|url=https://link.springer.com/article/10.1007/s00431-024-05806-x#:~:text=Study%20groups%20were%20comparable%20at,adverse%20events%20between%20the%20groups|publisher=link.springer.com|access-date=2026-01-23}}</ref>link.springer.com<ref>{{cite web|title=link.springer.com|url=https://link.springer.com/article/10.1007/s00431-024-05806-x#:~:text=Conclusion%3A%20The%20specific%20formulation%20of,probiotic%20interventions%20were%20well%20tolerated|publisher=link.springer.com|access-date=2026-01-23}}</ref>. These findings build on prior placebo-controlled trials where this same probiotic duo significantly reduced infant crying and fussiness within 7–14 dayscdhf.ca<ref>{{cite web|title=cdhf.ca|url=https://cdhf.ca/en/baby-probiotics-a-complete-guide-to-treating-colic/#:~:text=Studies%20show%20that%20certain%20probiotics,as%20little%20as%20seven%20days|publisher=cdhf.ca|access-date=2026-01-23}}</ref>link.springer.com<ref>{{cite web|title=link.springer.com|url=https://link.springer.com/article/10.1007/s00431-024-05806-x#:~:text=,formulations%20in%20ameliorating%20infant%20colic|publisher=link.springer.com|access-date=2026-01-23}}</ref>. In fact, research sponsored by the Canadian Digestive Health Foundation notes that colicky babies given B. longum KABP-042 and P. pentosaceus KABP-041 experienced notable relief by the end of the first week, with improvements in crying, irritability, and fussinesscdhf.ca<ref>{{cite web|title=cdhf.ca|url=https://cdhf.ca/en/baby-probiotics-a-complete-guide-to-treating-colic/#:~:text=Studies%20show%20that%20certain%20probiotics,as%20little%20as%20seven%20days|publisher=cdhf.ca|access-date=2026-01-23}}</ref>. This strain pair is now emerging as an effective alternative, especially for families who may not see success with L. reuteri. Delivery Form: Oil drop format (similar use as other infant drops). Dose is 5 drops daily (providing 10^9 CFU total) administered via dropper by mouth or mixed into cool liquid. The drops should be well shaken; like others, they should not be heated. (The product comes in a small bottle with a dropper for precise dosing.) Age Range: Young infants (newborns to ~12 months). Clinical studies enrolled babies as early as 2 weeks oldlink.springer.com<ref>{{cite web|title=link.springer.com|url=https://link.springer.com/article/10.1007/s00431-024-05806-x#:~:text=Otherwise%20healthy%20infants%20aged%202,were%20allowed|publisher=link.springer.com|access-date=2026-01-23}}</ref>. Culturelle’s Calm + Colic is marketed for “infants” in the colic age range (0–3+ months). It is appropriate for newborns showing colic symptoms, provided they are otherwise healthy (always consult a healthcare provider for infants under 1 month). Because colic resolves by ~5 months in most caseslink.springer.com<ref>{{cite web|title=link.springer.com|url=https://link.springer.com/article/10.1007/s00431-024-05860-5#:~:text=IC%20typically%20starts%20during%20the,the%20microbiota%2C%20changes%20in%20their|publisher=link.springer.com|access-date=2026-01-23}}</ref>link.springer.com<ref>{{cite web|title=link.springer.com|url=https://link.springer.com/article/10.1007/s00431-024-05860-5#:~:text=Conclusion%3A%20The%20synbiotic%20tested%20was,natural%20evolution%20of%20infant%20colic|publisher=link.springer.com|access-date=2026-01-23}}</ref>, probiotic use beyond 6 months is usually not necessary for colic specifically.
Summary:
Please note that all contributions to freem are considered to be released under the Creative Commons Attribution-ShareAlike 4.0 (see
Freem:Copyrights
for details). If you do not want your writing to be edited mercilessly and redistributed at will, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource.
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)